Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Isodiol International Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by Power4Playon Nov 19, 2017 10:00am
131 Views
Post# 26991720

RE:RE:RE:RE:RE:RE:WOW OPENING BIDS SET AT 1 DOLLAR

RE:RE:RE:RE:RE:RE:WOW OPENING BIDS SET AT 1 DOLLARMaybe because they are not grower. Others have X foot square and market is able to make some valuations. Here we are more into the pharma space and more complex to put a fair market value but with 20M$ revenues yearly already and growing, this should be put very much higher. If I’m not mistaken, the other 4 biggest revenues generators are canadian based with their major assets into canadian soil so can be listed on can major exchange ie TSX. ISOL will probably always be trading on CSE as my understanding of lately tsx new inforcement rules regarding canadian based company with US assets. 
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities